Rock Springs Capital Management LP Rocket Pharmaceuticals, Inc. Transaction History

Rock Springs Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$21.52 - $36.02 $8.68 Million - $14.5 Million	-403,270 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$39.41 - $47.25 $7,881 - $9,450	200 Added 0.05%	403,270 $17.9 Million
Q1 2021 May 17, 2021	BUY	$43.34 - $65.91 $117,018 - $177,957	2,700 Added 0.67%	403,070 $17.9 Million
Q4 2020 Feb 16, 2021	BUY	$23.3 - $59.57 $9.33 Million - $23.9 Million	400,370 New	400,370 $22 Million

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $875M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.